Main Sector of relevance\IRC classification 5. Electronics, IT and Telecommunication
5.45 Computer-aided design of potential drugs for AIDS therapy: glycolipids against the gp120 V3 loop of HIV-1
Developers’ contact information
1) State Scientific Institution “The United Institute of Informatics Problems”
220012, Minsk, Surganov St., 6
Теl.: +375 (17) 284-21-75; e-mail: itekan@newman.bas-net.by; URL: http://uiip.bas-net.by/
Summary
The aim of this project is to construct mathematical models describing the structure of atomic level and dynamic properties of the complexes formed by the V3 loop of HIV-1 subtype A, which is characteristic of the Republic of Belarus, with galactosylceramide, which water-soluble analogues inhibit viral replication by blocking the penetration of in susceptible cells by binding to a loop V3 according to the literature. The computer design of glycolipid’s modified forms is based on the calculated data. This forms will be able to more effectively block (compared with baseline lipid) of the main antigenic determinants of the virus with subsequent selection of the underlying structures of the most promising pharmacological substances to create an effective antiviral new generation.
Description
First applied approach to the prediction of
structural,functional,energy characteristics of the immunogenic
complexes "crown" of the V3 loop of HIV-1 provided hexapeptide
Gly-Pro-Gly-Arg/Gln-Ala-Phe, glycolipids with GalCer and its
water-soluble analogues in the absence of experimental data on
principles of spatial organization is a combination of a number of
modern computational methods.Based on the results of the calculations,
the key role is played by residues of phenylalanine and arginine
(glutamine) immunogenic "top" of HIV-1 upon binding to
glycolipids.Close to the experimental data, the calculated values of
free energy of formation of complexes of GalCer with peptides of the V3
loop showed the adequacy of the model and calculation scheme.Two
theoretically constructed water-soluble analogs of GalCer are often
close to the original molecule binding affinity to the central fragment
of the V3 loop, and can serve as basic structures for the rational
design of new effective antiviral drugs.
Despite the qualitative
agreement of simulation results with published data,carrying out such
calculations with an intact V3 loop is of interest to obtain more
accurate information about the interaction of glycolipids with protein
gp120. Similar studies should also be implemented for a wide variety of
modified forms of GalCer with their subsequent synthesis, testing and
selection of basic structures that represent promising pharmacological
substances to create a new generation of antivirals.
In addition,
the proposed model of structural complexes of the central fragment of
the V3 loop with GalCer can serve as a basis for better understanding
of the principles of the functioning of HIV-1, and can also be used in
subsequent studies of the relationship between structure and function
of the virus which is necessary for the successful implementation of
protein-engineering projects which are aimed at developing of antiviral
drugs with a wide range of therapeutic action.
Technology type
Technical advantages and economic benefits
Technology differentiation and uniqueness
Context in which technology was identified
Current research results were presented in reports at the conferences:
-
Second International Conference on “Advanced Information and
Telemedicine Technologies for Health” AITTH'2008, Minsk, October 1-3,
2008;
- Third International Conference “Supercomputer systems and applications” SSA'2010, Minsk, May 25-27, 2010;
- Third International Conference on “Mathematical Biology and Biophysics” ICMBB'2010, Pushchino (Russia), 10-15 October 2010.
Technological keywords
Biophysics, biochemistry, medicine, bioinformatics.
Development Stage
Intellectual property rights
Range of applications
- protein-engineering projects to develop medicines for the treatment of patients with AIDS;
- fundamental research aimed at studying the principles of functioning of HIV-1.
Classifier Used at the EU Innovation Relay Centres
Preferable Regions
Practical experience
Two of the calculated water-soluble analogs of GalCer were synthesized in the laboratory of Chemistry of lipids of the Institute of Bioorganic Chemistry of NAS of Belarus and tested for antiviral activity in RSPC Epidemiology and Microbiology. The activity of the synthesized compounds against HIV revealed during the tests.
Environmental impact
—
Type of collaboration sought
Terms and restrictions
—
Support provided at transfer of the technology